Publicaciones (64) Publicaciones de NURIA PARICIO ORTIZ

2024

  1. Contilisant+Tubastatin A Hybrids: Polyfunctionalized Indole Derivatives as New HDAC Inhibitor-Based Multitarget Small Molecules with In Vitro and In Vivo Activity in Neurodegenerative Diseases

    Journal of Medicinal Chemistry, Vol. 67, Núm. 18, pp. 16533-16555

2023

  1. Disease-Modifying Effects of Vincamine Supplementation in Drosophila and Human Cell Models of Parkinson’s Disease Based on DJ-1 Deficiency

    ACS Chemical Neuroscience, Vol. 14, Núm. 12, pp. 2294-2301

  2. Evaluation of type 1 diabetes mellitus as a risk factor of Parkinson's disease in a Drosophila model

    Journal of Experimental Zoology Part A: Ecological and Integrative Physiology, Vol. 339, Núm. 8, pp. 697-705

2022

  1. Antioxidant and Neuroprotective Effects of Carnosine: Therapeutic Implications in Neurodegenerative Diseases

    Antioxidants, Vol. 11, Núm. 5

  2. Exploring the link between Parkinson's disease and type 2 diabetes mellitus in Drosophila

    FASEB journal : official publication of the Federation of American Societies for Experimental Biology, Vol. 36, Núm. 8, pp. e22432

  3. Metabolic Alterations in a Drosophila Model of Parkinson’s Disease Based on DJ-1 Deficiency

    Cells, Vol. 11, Núm. 3

  4. Modeling of Parkinson’s disease in Drosophila based on DJ-1 deficiency

    Handbook of Animal Models in Neurological Disorders (Elsevier), pp. 467-480

2021

  1. A High-Throughput Chemical Screen in DJ-1β Mutant Flies Identifies Zaprinast as a Potential Parkinson’s Disease Treatment

    Neurotherapeutics, Vol. 18, Núm. 4, pp. 2565-2578

  2. A stress-responsive miRNA regulates BMP signaling to maintain tissue homeostasis

    Proceedings of the National Academy of Sciences of the United States of America, Vol. 118, Núm. 21

  3. Oxidative modification impairs SERCA activity in Drosophila and human cell models of Parkinson's disease

    Biochimica et Biophysica Acta - Molecular Basis of Disease, Vol. 1867, Núm. 7

2020

  1. Enhanced activity of glycolytic enzymes in Drosophila and human cell models of Parkinson's disease based on DJ-1 deficiency

    Free Radical Biology and Medicine, Vol. 158, pp. 137-148

2019

  1. Drosophila as a model system for the identification of pharmacological therapies in neurodegenerative diseases

    Insights into Human Neurodegeneration: Lessons Learnt from Drosophila (Springer Singapore), pp. 433-467

2018

  1. Cbt modulates Foxo activation by positively regulating insulin signaling in Drosophila embryos

    Biochimica et Biophysica Acta - Gene Regulatory Mechanisms, Vol. 1861, Núm. 9, pp. 878-891

2017

  1. Evolutionary conserved role of eukaryotic translation factor eIF5A in the regulation of actin-nucleating formins

    Scientific Reports, Vol. 7, Núm. 1

  2. Identification of potential therapeutic compounds for Parkinson's disease using Drosophila and human cell models

    Free Radical Biology and Medicine, Vol. 108, pp. 683-691

2016

  1. Scabrous overexpression in the eye affects R3/R4 cell fate specification and inhibits notch signaling

    Developmental Dynamics, Vol. 245, Núm. 2, pp. 166-174

2015

  1. Cabut/dTIEG associates with the transcription factor Yorkie for growth control

    EMBO Reports, Vol. 16, Núm. 3, pp. 362-369

2014

  1. The use of whole-mount in situ hybridization to illustrate gene expression regulation

    Biochemistry and Molecular Biology Education, Vol. 42, Núm. 4, pp. 339-347

  2. Why mammalian wound-healing researchers may wish to turn to Drosophila as a model

    Experimental Dermatology, Vol. 23, Núm. 8, pp. 538-542

2013

  1. Antioxidant compound supplementation prevents oxidative damage in a Drosophila model of Parkinson's disease

    Free Radical Biology and Medicine, Vol. 61, pp. 151-160